Tuesday, 29 October 2024
ICN2 and CSIC Spin-off INBRAIN Neuroelectronics Raises $50 Million Series B Funding
This major investment will accelerate the development of its graphene-based therapeutic neural interfaces.

Tuesday, 29 October 2024
This major investment will accelerate the development of its graphene-based therapeutic neural interfaces.
Monday, 14 October 2024
The project, led by Dr Salvio Suárez, is focused on producing biomaterials with antimicrobial properties that can be used to treat lesions and skin regeneration. Caixa Impulse aims to promote the creation of new products, services and companies related to life sciences and health.
Tuesday, 10 September 2024
This ICN2 and CSIC spin-off, committed to researching materials and solutions for capturing carbon dioxide at the industry emission point and reducing its atmospheric levels, has demonstrated the efficacy of one of its products in a space provided by the company SACYR.
Friday, 27 September 2024
The revolutionary clinical procedure took place at the Salford Royal Hospital in Manchester. INBRAIN, co-founded by researchers from ICN2 and CSIC, confirms its position at the forefront of precision neurology.
Thursday, 04 July 2024
This initiative, led by ICN2 researchers, aims to create new technologies for producing moisturising and analgesic clothing for cyclists.